Madrigal Pharmaceuticals (MDGL) Inventory (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has 3 years of Inventory data on file, last reported at $112.1 million in Q1 2026.

• Inventory for Q1 2026 came in at $112.1 million, up 102.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $112.1 million (up 102.87% YoY), and the FY2025 annual result was $74.8 million, up 119.68% from the prior year.
• Inventory climbed to $112.1 million in Q1 2026 per MDGL's latest filing, from $74.8 million in the prior quarter.
• Over five years, Inventory peaked at $112.1 million in Q1 2026 and troughed at $854000.0 in Q1 2024.
• A 3-year average of $47.3 million and a median of $55.2 million in 2025 frame the typical range for Inventory.
• The sharpest annual moves came in 2025 and 2026: Inventory surged 6368.5% in 2025, then surged 102.87% in 2026.
• A 3-year view of Inventory shows it stood at $34.1 million in 2024, then soared by 119.68% to $74.8 million in 2025, then jumped by 49.74% to $112.1 million in 2026.
• Business Quant data shows MDGL's Inventory at $112.1 million in Q1 2026, $74.8 million in Q4 2025, and $69.3 million in Q3 2025.